ArticleThe New England journal of medicine2020
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it
ArticleThe New England journal of medicine2020
No numbers read from the abstract.